Anal and Stomal Procedures without CC/MCC DRG Reimbursement

DRG 349 includes inpatient admissions for anal and stomal procedures without Major Complication or Comorbidity or Complication or Comorbidity, covering procedures like fistula repair, hemorrhoidectomy, and stoma creation or revision. This matters for inpatient reimbursement because the Diagnosis-Related Group assignment determines the standardized Medicare payment rate and reflects expected resource use for uncomplicated surgical cases.

DRG 349 Overview

DRG 349 covers inpatient admissions for patients undergoing anal and stomal procedures without a Major Complication or Comorbidity and without a Complication or Comorbidity. Typical cases include elective or urgent procedures such as anal fistula repair, hemorrhoidectomy, and creation or revision of a stoma when no significant comorbid conditions are present. This Diagnosis-Related Group groups cases with similar resource use to establish a single Medicare payment rate for the inpatient stay. Understanding this grouping is important because it determines base payment and influences documentation and coding that support appropriate reimbursement.

Acute surgical technique and perioperative management trials: randomized or observational studies comparing minimally invasive versus open approaches for anal and stomal procedures (for example, local excision versus more extensive resection, or laparoscopic stoma creation versus open) and testing optimized perioperative pathways such as enhanced recovery after surgery (ERAS) protocols. These trials enroll adult inpatients undergoing index procedures captured in this DRG to evaluate intraoperative complications, length of stay, and early readmission within 30 days. Results inform surgeons and hospital administrators about approaches that reduce LOS and immediate resource use, directly affecting inpatient reimbursement and quality metrics for payers and providers.
Comparative effectiveness studies of wound, stoma, and continence management strategies in the early post-op period: pragmatic trials or cohort studies assessing different wound care regimens, ostomy appliance systems, negative-pressure therapy for perineal wounds, or protocols for prevention of peristomal skin complications. These studies focus on the heterogeneous inpatient population after anal resections or stoma creation who are at high risk of wound breakdown, infection, or appliance-related readmission, and they measure outcomes such as infection rates, need for reintervention, and early discharge readiness. Findings guide inpatient nursing protocols, discharge planning and device selection, which can reduce downstream costs and readmissions—key concerns for payers managing bundled payments.
Post-discharge outcomes and health services research evaluating readmission drivers, patient education interventions, and transitional care models for patients discharged after anal and stomal procedures: cohort studies or implementation trials testing structured discharge education, telehealth follow-up, or care coordination with ostomy nurses to reduce 30- and 90-day readmissions and emergency visits. These studies enroll the typical DRG population including older adults and medically complex patients whose social determinants or comorbidities affect recovery, and they quantify impacts on downstream utilization and patient-reported outcomes such as functional status and stoma self-care. Evidence from this research helps hospitals and payers design targeted interventions to lower avoidable readmissions and optimize post-acute resource allocation.

Acute surgical technique and perioperative management trials: randomized or observational studies comparing minimally invasive versus open approaches for anal and stomal procedures (for example, local excision versus more extensive resection, or laparoscopic stoma creation versus open) and testing optimized perioperative pathways such as enhanced recovery after surgery (ERAS) protocols. These trials enroll adult inpatients undergoing index procedures captured in this DRG to evaluate intraoperative complications, length of stay, and early readmission within 30 days. Results inform surgeons and hospital administrators about approaches that reduce LOS and immediate resource use, directly affecting inpatient reimbursement and quality metrics for payers and providers.
Comparative effectiveness studies of wound, stoma, and continence management strategies in the early post-op period: pragmatic trials or cohort studies assessing different wound care regimens, ostomy appliance systems, negative-pressure therapy for perineal wounds, or protocols for prevention of peristomal skin complications. These studies focus on the heterogeneous inpatient population after anal resections or stoma creation who are at high risk of wound breakdown, infection, or appliance-related readmission, and they measure outcomes such as infection rates, need for reintervention, and early discharge readiness. Findings guide inpatient nursing protocols, discharge planning and device selection, which can reduce downstream costs and readmissions—key concerns for payers managing bundled payments.
Post-discharge outcomes and health services research evaluating readmission drivers, patient education interventions, and transitional care models for patients discharged after anal and stomal procedures: cohort studies or implementation trials testing structured discharge education, telehealth follow-up, or care coordination with ostomy nurses to reduce 30- and 90-day readmissions and emergency visits. These studies enroll the typical DRG population including older adults and medically complex patients whose social determinants or comorbidities affect recovery, and they quantify impacts on downstream utilization and patient-reported outcomes such as functional status and stoma self-care. Evidence from this research helps hospitals and payers design targeted interventions to lower avoidable readmissions and optimize post-acute resource allocation.

OpenPayer

Summary & Overview

Anal and Stomal Procedures without CC/MCC: Inpatient Reimbursement Overview

DRG 349 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes